Clinical Trials Directory

Trials / Terminated

TerminatedNCT00003040

S9709, Laser Surgery Plus Radiation Therapy in Treating Patients With Early Stage Cancer of the Larynx

A Phase II Study to Evaluate Transoral CO2 Laser Supraglottic Laryngectomy and Irradiation in Stage I, II and III Squamous Cell Carcinoma of the Supraglottic Larynx

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
42 (actual)
Sponsor
SWOG Cancer Research Network · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Laser surgery for cancer of the larynx may have fewer side effects and improve recovery. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy and laser surgery may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of laser surgery plus radiation therapy in treating patients with early stage cancer of the larynx.

Detailed description

OBJECTIVES: I. Assess the feasibility of treating untreated stage I, II and selected stage III squamous cell carcinoma of the supraglottic larynx with endoscopic surgery and irradiation. II. Estimate the 3 year progression free survival and describe the location of disease progression. OUTLINE: Patients receive carbon dioxide laser laryngectomy within 28 days following protocol registration. Patients with N1 disease may undergo an optional neck dissection ipsilateral to the neck mass. Neck dissection includes complete removal of at least lymph node levels 2-4. Radiation therapy begins 14 days following laser surgery. Patients are followed every 3 months for the first year, every 6 months for the second year, and every 12 months thereafter until death. PROJECTED ACCRUAL: There will be 50 patients accrued into this study in 3 years with an estimated accrual rate of 20 patients per year.

Conditions

Interventions

TypeNameDescription
PROCEDURElaser surgeryCO2 supraglottic laryngectomy within 28 days following registration with neck dissection as needed
RADIATIONradiation therapy200 cGy per day, five days per week for approximately 6 weeks, to begin 14 days after laser surgery

Timeline

Start date
1997-09-01
Primary completion
2007-02-01
Completion
2007-12-01
First posted
2004-03-01
Last updated
2012-06-15

Locations

12 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00003040. Inclusion in this directory is not an endorsement.